The estimated Net Worth of Nabil Shabshab is at least $450 ezer dollars as of 1 September 2023. Mr Shabshab owns over 3,686 units of Inogen Inc stock worth over $450,065 and over the last 11 years he sold INGN stock worth over $0.
Mr has made over 15 trades of the Inogen Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 3,686 units of INGN stock worth $42,610 on 1 September 2023.
The largest trade he's ever made was exercising 22,502 units of Inogen Inc stock on 8 May 2015 worth over $1,660,648. On average, Mr trades about 5,574 units every 95 days since 2013. As of 1 September 2023 he still owns at least 38,933 units of Inogen Inc stock.
You can see the complete history of Mr Shabshab stock trades at the bottom of the page.
Nabil Shabshab is the CEO, Pres & Director at Inogen Inc.
Mr Shabshab is 56, he's been the CEO és Pres & Director of Inogen Inc since . There are 6 older and 13 younger executives at Inogen Inc. The oldest executive at Inogen Inc is Benjamin Anderson-Ray, 65, who is the Independent Director.
Nabil's mailing address filed with the SEC is C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA, CA, 93117.
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen és Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Inogen Inc executives and other stock owners filed with the SEC include: